Preview Mode Links will not work in preview mode

Sep 8, 2021

In part two of our conversation with Villanova visiting professor of philosophy Emma Stamm, we discuss the "psychedelic industry's" increasing fixation on digital capitalism. Looking at apps like MyDelica and hardware like Kernel's brain-scanning helmet, we discuss how the social implications of this technology extend...


Aug 12, 2021

In part one of our conversation with Villanova visiting professor of philosophy Emma Stamm, we discuss Mark Fisher’s Acid Communism, leftist thought in psychedelia, Jacques Derrida’s hauntology, and Byung-Chul Han’s Psychopolitics: Neoliberalism and New Technologies of Power.

Co-hosts: Neşe Devenot, Brian...


Aug 5, 2021

In Part Two, the crew continues their break down of Atai Life Sciences' founder and COMPASS Pathways investor Christian Angermayer's recent appearance on right-wing YouTuber Dave Rubin's "The Rubin Report."

Co-hosts: Brian Normand, Neşe Devenot, David Nickles, Brian Pace, Russell Hausfeld, Sarvesh Ramprakash. Editor:...


Jul 29, 2021

In Part One, the crew breaks down Atai Life Sciences' founder and COMPASS Pathways investor Christian Angermayer's recent appearance on right-wing YouTuber Dave Rubin's "The Rubin Report."

Co-hosts: Brian Normand, Neşe Devenot, David Nickles, Brian Pace, Russell Hausfeld, Sarvesh Ramprakash. Editor: Matt Payne

Watch:


Jul 22, 2021

The crew reviews Michael Pollan’s recent New York Times Op-Ed "How Should We Do Drugs Now?
 
Co-hosts: Neşe Devenot, Brian Normand, David Nickles, Brian Pace. Editor: Matt Payne
 
Additional links: 
 
Michael Pollan: Not So Fast on Psychedelic Mushrooms | New York Times
 
#1 - We Hope Michael Pollan Changes His...